Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats

Area of Science:

• Neuroscience
• Pharmacology
• Cognitive Science

Background:

• Galanin, a neuroactive peptide, coexists with acetylcholine in the basal forebrain.
• Galanin inhibits cholinergic functions and can impair memory task performance.
• Understanding galanin's effects on memory is crucial for cognitive research.

Purpose of the Study:

• To compare the effects of galanin on a spatial delayed nonmatching-to-sample task with those of scopolamine and NMDA receptor antagonists (ketamine, MK-801).
• To investigate whether galanin's disruption of memory performance is specific to mnemonic capabilities.

Main Methods:

• An operant, spatial, delayed nonmatching-to-sample task was used in rats.
• Rats were administered galanin, scopolamine, ketamine, or MK-801.
• Performance measures included choice accuracy, session duration, and discrimination accuracy.

Main Results:

• Galanin, scopolamine, and MK-801 impaired choice accuracy in a dose-dependent and delay-independent manner.
• Ketamine did not systematically influence choice accuracy.
• Other behavioral measures were also analyzed to assess the specificity of the disruption.

Conclusions:

• Galanin disrupts performance in memory tasks requiring delayed responding.
• The observed disruption by galanin is not specific to mnemonic capabilities.
• Galanin's effects share similarities with other cognitive impairing agents like scopolamine and MK-801.